TNF and prostate carcinoma: Orai1 knockdown or ectopic expression of Orai1 dominant-negative mutants in prostate cancer cells downregulated SOCE activity and decreased susceptibility to diverse apoptosis-inducing stimuli including thapsigargin, tumor necrosis factor-α (TNF-α) and cisplatin.